Dried blood spot IP-10 as a biomarker of tuberculosis severity and treatment responses: results from a phase IIb trial of adjunctive acetylsalicylic acid and ibuprofen.
Overview & Synopsis
Open access biomedical research article published in Front Immunol.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Dried blood spot IP-10 as a biomarker of tuberculosis severity and treatment responses: results from a phase IIb trial of adjunctive acetylsalicylic acid and ibuprofen. |
|---|---|
| Author / Organization | Høgbakk Edlund I, Alonso-Rodriguez N, Sopegno C, Farrés J, Gogichadze N, Arias L, Fonseca KL, Otwombe K, Waja Z, Moloantoa T, Pillay N, Seiphetlo T, Martinson N, Vilaplana C, Dyrhol-Riise AM |
| Subject & Discipline | Front Immunol |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-120706 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |